Evidence map›Paper›PMID 33586403›Full record

ArticleMolecular imaging and radionuclide therapy2021

Nilüfer Bıçakçı, Murat Elli

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06612567 (Normal Variants and Pitfalls of 18F_FDG PET/CT Imaging in Pediatric Oncology), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06612567 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Normal Variants and Pitfalls of 18F_FDG PET/CT Imaging in Pediatric Oncology

TypeobservationalSponsorAssiut UniversityRan2024 to 2026Enrolled120ConditionsPitfalls of PET Scan on PediatticArmsPET/CT
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. PET scout: A valuable technology in pediatricEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Nilüfer BıçakçıUniversity of Health Sciences Turkey, Samsun Training and Research Hospital, Clinic of Nuclear Medicine, Samsun, Turkey.ORCID 0000-0003-4124-1225
Murat Elliİstanbul Medipol University Faculty of Medicine, Department of Pediatric Oncology, İstanbul, Turkey.ORCID 0000-0002-0476-5452
Istanbul Medipol University · TRSamsun University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The aim of the study was to evaluate the utility of Methods: This study included 52 patients (32 boys, 20 girls) who were referred to our clinic between November 2008 and December 2018 with the diagnosis of malignancy. The patients were evaluated retrospectively. Median age of the patients was 13 years (range 2-17). Results: Conclusion:

Indexed as

18F-FDG PET/CTchildhood malignancyresponserestagingstaging

Identifiers

PMID33586403
PMCPMC7885281
OpenAlexW3126506968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.